Skip to main content
S&P 5007,541.40-0.51%DOW51,983.98+0.41%NASDAQ25,164.36-1.07%BTC$77,142.00-1.60%ETH$2,258.53-1.35%GOLD$3,958.40-0.28%OIL$96.61+0.16%
Smart Investors Daily
SID Premium
XB

NASDAQ · XBIO

Xenetic Biosciences, Inc.

Healthcare · Biotechnology

$2.06

Up+$0.01 (+0.49%)

Updated Nov 3, 2026, 8:04 AM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap
3.76M
P/E ratio
-1.19
Dividend yield
0.00%
52-week range
$1.58 – $4.94
Volume
29.7K
Avg. volume
845.57K

Price performance · XBIO

XBIO price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Nov 2, 2026

XBIO closed at $2.06 after 21 trading sessions, down 6.36% for the selected period.

Last close
$2.06
Period change
-6.36%
Period low
$1.72
Period high
$2.21
Daily close
View OHLC price history
XBIO OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Nov 2, 2026$2.09$2.27$2.00$2.0629.7K
Oct 30, 2026$2.14$2.15$1.95$2.0532.62K
Oct 29, 2026$2.13$2.21$2.0617$2.1234.45K
Oct 28, 2026$1.90$2.135$1.86$2.10139.63K
Oct 27, 2026$1.81$1.90$1.781$1.824610.33K
Oct 26, 2026$1.70$1.859$1.5801$1.8545.98K
Oct 23, 2026$1.90$1.9002$1.72$1.7222.12K
Oct 22, 2026$2.03$2.04$1.90$1.9318.88K
Oct 21, 2026$2.00$2.03$1.97$2.026.83K
Oct 20, 2026$1.96$2.05$1.96$2.0011.49K
Oct 19, 2026$1.93$1.95$1.85$1.9310.12K
Oct 16, 2026$1.98$2.00$1.92$1.9917.53K
Oct 15, 2026$2.09$2.10$1.885$2.0151.38K
Oct 14, 2026$2.07$2.14$2.07$2.1012.57K
Oct 13, 2026$2.14$2.175$2.0401$2.1035.74K
Oct 12, 2026$2.14$2.27$2.11$2.128.5K
Oct 9, 2026$2.195$2.2311$2.13$2.1310.23K
Oct 8, 2026$2.18$2.18$2.10$2.1213.55K
Oct 7, 2026$2.11$2.21$2.11$2.2115.56K
Oct 6, 2026$2.19$2.3405$2.1001$2.1214.73K
Oct 5, 2026$2.23$2.29$2.19$2.209.53K

Latest XBIO news

The latest Smart Investors Daily articles mentioning XBIO.

Stock researchCompany · Overview

XBIO research

Overview

Company profile and research snapshot.

Company profile

Xenetic Biosciences Inc is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. The company's DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in the progression of many human cancers. Xenetic is also focused on advancing its systemic DNase program into the clinic as an adjunctive therapy for pancreatic carcinoma and other locally metastatic solid tumors.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
XBIO recent ratings
DateFirmRatingTarget
Apr 9, 2025HC Wainwright & Co.Neutral—
Mar 20, 2025HC Wainwright & Co.Neutral—
Dec 5, 2024HC Wainwright & Co.Neutral—
Nov 22, 2024HC Wainwright & Co.Neutral—
Aug 20, 2024HC Wainwright & Co.Neutral—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 15, 2026

Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma

("PeriNess"), has informed the Company that the first patient has been dosed in an investigator-initiated clinical study evaluating systemic recombinant human DNase in combination with anti-CD19 CAR T-cell therapy in patients with large B-cell lymphoma ("LBCL") at the Tel Aviv Sourasky University Medical Center ("Ichilov Center") in Israel.The milestone marks the first clinical evaluation of Xenetic's systemic DNase technology as an adjunct to CAR T-cell therapy.

Benzinga · Oct 5, 2026

12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers Apimeds Pharmaceuticals (AMEX:APUS) stock moved upwards by 76.7% to $5.69 during Monday's pre-market session. The market value of their outstanding shares is at $4.8 million. Alector (NASDAQ:ALEC) shares

Benzinga · Sep 22, 2026

12 Health Care Stocks Moving In Tuesday's Intraday Session

Gainers Jaguar Health (NASDAQ:JAGX) stock increased by 304.5% to $10.8 during Tuesday's regular session. The company's market cap stands at $1.1 million. Greenland Mines (NASDAQ:GRML) shares moved upwards by

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.

Featured By